Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

R-CLOSTRIDIUM HISTOLYTICUM COLLAGENASE H SH-OLIGOPEPTIDE-60.

Insufficient Data / SKIN CONDITIONING

R-Clostridium Histolyticum Collagenase H SH-Oligopeptide-60 is a single-chain recombinant fusion peptide containing a collagenase component. It is designed to influence skin structure and promote repair, aiming to reduce the appearance of wrinkles and enhance skin firmness.

Skin Conditioning Anti-aging Wrinkle reduction Skin structure strengthening

Science

This ingredient functions via its collagenase component, an enzyme mixture (AUX-I and AUX-II) derived from Clostridium histolyticum, which precisely hydrolyzes Type I and Type III collagen in its native triple helical conformation. This leads to the controlled lysis of collagen deposits, a process that, in cosmetic applications, is suggested to stimulate the regeneration of mature skin, strengthen its structure, and visibly reduce wrinkles by mimicking the skin's natural repair mechanisms through endogenous signaling.


Research

Low confidence
Effective range N/A
Optimal

N/A


Transparency

Not commonly dusted

Topical optimal concentrations and typical usage percentages for this cosmetic ingredient are not specified in the available research, making it impossible to establish a 'dusting' threshold or assess common dusting practices.


The Formula

Solubility
Water
Optimal pH 6 – 8
0 7 14

Stability

The ingredient, specifically the Collagenase H component, exhibits optimal activity within a pH range of 6.0-8.0. Solutions maintained at neutral pH (approximately 7.0) with a calcium concentration of 0.3-0.5 mM retain activity for at least 5 hours at 37°C. For prolonged stability, storage at -20°C is recommended for several months; however, repeated freezing and thawing cycles should be avoided to prevent activity loss. Calcium is an essential cofactor for its enzymatic activity.

Conflicts

  • EDTA
  • EGTA
  • Cys
  • His
  • DTT
  • 2-mercaptoethanol

Safety

CIR Status
Not reviewed
Sensitization risk Moderate

The related injectable drug, Collagenase Clostridium Histolyticum (CCH-aaes, brand name Qwo), received US FDA approval in 2020 for moderate-to-severe cellulite, with an associated Risk Evaluation and Mitigation Strategy (REMS). Human pharmacokinetic studies for the injectable CCH reported no quantifiable plasma concentrations of its components (AUX-I or AUX-II) following subcutaneous doses up to 3.36 mg. Common adverse events for the injectable form were localized to the injection site, primarily bruising (97.6%), pain (87.8%), and edema/swelling (46.3%). For the cosmetic ingredient, warnings suggest a likelihood of irritation, with increased risk at higher concentrations or in combination with other problematic ingredients, potentially leading to irritation, inflammation, or dryness.


Your Skin

No Normal
No Dry
No Oily
No Sensitive
Irritancy High
Comedogenicity Unknown

Our Assessment

Insufficient Data

While the enzymatic mechanism for collagen hydrolysis presents a theoretical pathway for skin remodeling and anti-aging benefits, there is a critical lack of specific clinical efficacy and comprehensive safety data for its topical application in cosmetics, coupled with warnings regarding potential skin irritation.


Related

Finding similar ingredients…